A review of premalignant oral conditions.
The value of mass oral cancer screenings has come under scrutiny, as a consequence of a lack of improvement in the long-term outcomes associated with oral carcinoma over the past several decades. However, it is generally accepted that most oral carcinomas are preceded by visible changes to the mucosa and certain high risk lesions have been identified. The responsibility to evaluate the mucosal tissues of the oral cavity clearly falls under the purview of the dentist. The dentist must clearly grasp the distinction between reactive lesions which usually change in 7 to 14 days and malignant and premalignant lesions which do not. Therefore, appropriate diagnostic procedures (i.e., biopsy of the lesion) must be implemented as a matter of course in the evaluation of any lesion that does not respond to usual therapy in 7 to 14 days.
Huber
Michael A
MA
Department of Dental Diagnostic Science, The University of Texas Health Science Center at San Antonio Dental School, San Antonio, USA.
D000328:Adult; D002613:Cheilitis / Q000473:pathology / Q000628:therapy; D003937:Diagnosis, Differential; D004919:Erythroplasia / Q000473:pathology*; D005260:Female; D006801:Humans; D007972:Leukoplakia, Oral / Q000209:etiology / Q000473:pathology* / Q000601:surgery; D017676:Lichen Planus, Oral / Q000473:pathology; D008297:Male; D009062:Mouth Neoplasms / Q000473:pathology*; D009914:Oral Submucous Fibrosis / Q000209:etiology / Q000473:pathology; D010787:Photosensitivity Disorders / Q000473:pathology / Q000628:therapy; D011230:Precancerous Conditions / Q000473:pathology*; D014030:Tobacco, Smokeless / Q000009:adverse effects